Reconstructing Forked Corpus Spongiosum in Hypospadias Repair

August 9, 2022 updated by: Zhangbin, Children's Hospital of Fudan University

Application and Efficacy of Reconstructing Forked Corpus Spongiosum in Hypospadias Repair

Hypospadias is one of the most common genital malformations in children. The high incidence of hypospadias, which occurs in 1 in 200 to 300 live births, means that it affects a large number of patients. Surgery is the only way to repair hypospadias. Over 400 techniques have been described for hypospadias repair. However, the surgical success rate of hypospadias is still not ideal. Although the surgical success rate of distal hypospadias has reached more than 85%, the complications of proximal hypospadias are still as high as 30-68%. How to improve surgical skills and reduce the postoperative complications is quite a challenge for pediatric urologists.

In the preliminary clinical work, the investigators have tried to apply the technique of reconstructing forked corpus spongiosum (FCS) in hypospadias repair with urethral plate preservation. It has been confirmed that this technique was effective in reducing postoperative complications of this type of hypospadias repair. In order to promote the technology of reconstructing FCS, the investigators need to perform this technology in various types of hypospadias and evaluate its true effectiveness. Therefore, the investigators need to design a prospective, randomized, parallel-controlled, single-blind, and superior clinical trial to analyze the efficacy of reconstructing FCS in hypospadias repair.

In this study, the investigators will perform one-stage surgical repair on children with primary hypospadias by the same surgeon in Urology Department, Children's Hospital of Fudan University, Shanghai, China. Participants will be random grouped: Routine standardized surgery with reconstructing FCS group and Routine standardized surgery group. All participants will be closely followed up and regularly evaluated after surgery, including postoperative complications, HOSE objective score of cosmetic outcome and voiding function. By collecting all data and conducting statistical analysis, the investigators will evaluate the followings: (1) the correlation between the penile curvature and the development of FCS; (2) the effect of reconstructing FCS on the complications of primary hypospadias repair; (3) the effect of reconstructing FCS on the cosmetic outcome; (4) the influence of reconstructing FCS on postoperative voiding function.

Based on this clinical randomized controlled study, the investigators intend to prove the feasibility and effectiveness of the new technology of reconstructing FCS in various types of hypospadias repair. The study will provide a reliable basis for the promotion of this technology for hypospadias repair in order to improve the quality of life for children with hypospadias.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

260

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 months to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • children with primary hypospadias
  • one-stage surgical repair

Exclusion Criteria:

  • staged surgery repair
  • micropenis
  • reoperation for postoperative complications
  • using testosterone or male hormones preoperatively

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Routine surgery with reconstructing FCS
The participants undergo FCS reconstruction during the routine standardized surgery.
During the routine standardized surgery, the FCS should be cut off along both sides of the middle urethral plate before dissecting the glans wings and then dissected along the penile tunica albuginea closely from the near to the far side of the penis until the top of the penis head was reached. The corpus spongiosum on both sides will be reserved for the two wings of the glans. The two wings of the glans should be carefully expanded to at least the 3 o'clock and 9 o'clock positions of the penis. Some cases of small glans should be dissected to the 2 o'clock and 10 o'clock positions to close the two wings of the glans with no tension when performing glansplasty. Additionally, the original FCS on both sides should be combined at the coronal sulcus, thereby covering the surface of the new urethra.
When the urethral plate can be preserved after degloving, the investigators chose the surgical method according to the width of the urethral plate. If the width of the urethral plate is ≥6 mm, tubularized incised plate (TIP) urethroplasty will be performed, whereas if the width of the urethral plate is <6 mm, the onlay island flap (ONLAY) technique will be performed. When the urethral plate can not be preserved after degloving, transverse preputial island flap urethroplasty (Duckett) will be performed.
Active Comparator: Routine surgery
The participants undergo routine standardized surgery.
When the urethral plate can be preserved after degloving, the investigators chose the surgical method according to the width of the urethral plate. If the width of the urethral plate is ≥6 mm, tubularized incised plate (TIP) urethroplasty will be performed, whereas if the width of the urethral plate is <6 mm, the onlay island flap (ONLAY) technique will be performed. When the urethral plate can not be preserved after degloving, transverse preputial island flap urethroplasty (Duckett) will be performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if any complications including residual chordee, fistula, diverticulum, glans dehiscence, meatus stenosis, or urethral stricture happeded.
1 to 6 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Residual chordee
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if residual chordee happeded.
1 to 6 months after surgery
Fistula
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if fistula happeded.
1 to 6 months after surgery
Diverticulum
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if diverticulum happeded.
1 to 6 months after surgery
Glans dehiscence
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if glans dehiscence happeded.
1 to 6 months after surgery
Meatus stenosis
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if meatus stenosis happeded.
1 to 6 months after surgery
Urethral stricture
Time Frame: 1 to 6 months after surgery
It is a binary variable (1/0) that needs repeated measurement. The variable would be setted into "1", if urethral stricture happeded.
1 to 6 months after surgery
Hypospadias objective scoring evaluation
Time Frame: at 6 month after surgery
It is an objective scoring system for evaluating the cosmetic outcome of hypospadias surgery. The scoring system is designed so that the minimum total score would be 5, corresponding to a worst score for each variable, to a maximum total of 16, equivalent to the best score for each variable.
at 6 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2023

Primary Completion (Anticipated)

September 30, 2023

Study Completion (Anticipated)

September 30, 2023

Study Registration Dates

First Submitted

August 24, 2020

First Submitted That Met QC Criteria

August 28, 2020

First Posted (Actual)

August 31, 2020

Study Record Updates

Last Update Posted (Actual)

August 10, 2022

Last Update Submitted That Met QC Criteria

August 9, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Zhangbin_001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypospadias

3
Subscribe